Pancreato-hepatobiliary neuroendocrine tumors diagnosed through endoscopic ultrasound: Clinical characteristics and factors associated with high-grade lesions

Table 3 Clinical features of patients with pancreato-hepatobiliary neuroendocrine tumors (n = 36)

		No. of patients	Percentage (%)
Age	< 40 years	9	25.0
	> 40 years	27	75.0
Gender	Males	18	50.0
	Females	18	50.0
PHB regions affected	Pancreas	20	55.6
	Others	16	44.4
Grade of NETs	WHO grade I (Ki 67: < 2%)	19	52.8
	WHO grade II (Ki 67: 2-20%)	5	13.9
	WHO grade III (Ki 67: > 20%)	12	33.3
Histologic type	Large cell	17	47.2
	Small cell	8	22.2
	Mixed	1	2.8
	Undetermined	10	27.8
Functionality	Non-functioning	32	88.9
	Functioning	4	11.1

PHB: Pancreato-hepatobiliary; LN: Lymph node; NET: Neuroendocrine tumor.